Last reviewed · How we verify

NCT03999398

Short and Long-term Results of PCI in no Touch Vein-graft.

Status unknown Last updated 9 March 2021
What this trial tests

trial testing Percutaneous coronary intervention (PCI) in Percutaneous Coronary Intervention in 260 participants. Status unknown.

Timeline
1 October 2017
Primary endpoint
1 January 2022
2 January 2022

Quick facts

Lead sponsorRegion Örebro County
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment260
Start date1 October 2017
Primary completion1 January 2022
Estimated completion2 January 2022
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Region Örebro County — full company profile →

Who can join

Eligibility, any sex, with Percutaneous Coronary Intervention or Saphenous Vein. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Coronary artery disease is one of the biggest health issue worldwide.The treatment, in a large part of the patients, implicates a so called bypass-operation, that consists in to connect new vascular conduits (grafts) beyond the narrowed coronary vessels to improve the blood supply to the heart. One of the graft that is commonly used is the saphenous vein from the leg. The disadvantage of the saphenous vein graft is the predisposition to early obstruction. The international literature shows the following grades of occlusion: 15% in the first year and 40% after 10 year. At the Cardio-Thoracic Clinic of the University hospital of Örebro has been developed a new method to harvest the saphenous vein together with the surrounding fat-tissue. This technique, called no-touch technique, has the advantage to reduce the damages to the vein during the harvesting, showing a substantially reduced risk for future occlusion (5% after 18 months and 10% after 8,5 years). The aim of the PhD project is to evaluate the results of the no-touch technique in compare to the conventional technique for the venous graft harvesting. The focus of the study is to analyse all the operated patients in our clinic who underwent a post-operative coronary angiography do to angina pectoris (heart pain). All the patients who received a stent during the post-operative angiography will be analysed in detail and one will compare the occlusion grade and the rate of major adverse cardiac events (MACE). This study is the first and the only one in the world that will examine the long-term results of the no-touch technique in particular after the stenting of the venous graft.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Quality of Life After Percutaneous Coronary Intervention in No-Touch Saphenous Vein Grafts is Significantly Better Than in Conventional Vein Grafts.
    Ferrari G, Karlsson J, Cao Y, Geijer H, et al · · 2022 · cited 5× · PMID 35976202 · DOI 10.21470/1678-9741-2021-0576
  2. Long-term results of percutaneous coronary intervention in no-touch vein grafts are significantly better than in conventional vein grafts.
    Ferrari G, Geijer H, Cao Y, Graf U, et al · · 2025 · cited 3× · PMID 38253348 · DOI 10.1177/02676591241230012

Verify or expand the search:

Other trials of Percutaneous coronary intervention (PCI)

Trials testing the same drug.

Other recruiting trials for Percutaneous Coronary Intervention

Currently open trials in the same condition.

Other Region Örebro County trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03999398.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing